M MELTECH Trademark
Trademark Overview
On Thursday, January 11, 2024, a trademark application was filed for M MELTECH with the United States Patent and Trademark Office. The USPTO has given the M MELTECH trademark a serial number of 98353406. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, September 17, 2024. This trademark is owned by Dexcel Pharma Technologies Ltd.. The M MELTECH trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations in the form of orally disintegrating tablets and orally disintegrating medicaments for the treatment of genetic, central nervous system, endocrine, gastrointestinal, hepatic, biliary, immunological, allergic, pulmonary, infectious, inflammatory, menopausal, nutritional, metabolic, diabetes, autoimmune, musculoskeletal, connective tissue, neurological, psychiatric, respiratory, gynecology, obstetric, oncological, fungal and viral diseases and disorders
General Information
| Serial Number | 98353406 |
| Word Mark | M MELTECH |
| Filing Date | Thursday, January 11, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, September 17, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, September 17, 2024 |
Trademark Statements
| Description of Mark | The mark consists of the word "MELTECH" appearing in stylized font with a stylized "M" appearing to the left of the wording and extending under the letters "MEL". |
| Goods and Services | Pharmaceutical preparations in the form of orally disintegrating tablets and orally disintegrating medicaments for the treatment of genetic, central nervous system, endocrine, gastrointestinal, hepatic, biliary, immunological, allergic, pulmonary, infectious, inflammatory, menopausal, nutritional, metabolic, diabetes, autoimmune, musculoskeletal, connective tissue, neurological, psychiatric, respiratory, gynecology, obstetric, oncological, fungal and viral diseases and disorders |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 11, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | Thursday, March 1, 2018 |
| First Use In Commerce Date | Thursday, March 1, 2018 |
Trademark Owner History
| Party Name | Dexcel Pharma Technologies Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Jerusalem 9123901
IL |
| Party Name | Dexcel Pharma Technologies Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Jerusalem 9123901
IL |
Trademark Events
| Event Date | Event Description |
| Thursday, January 11, 2024 | NEW APPLICATION ENTERED |
| Sunday, May 12, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, August 7, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, August 13, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 28, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 17, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 17, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
